Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Redbaron2211on Jun 27, 2019 8:56pm

104 Views

Post# 29872194

RE:Preliminary results

We likely wont see much for efficacy data its slated for the second half of 2019 but Dr. Piotr Witkowski will know if the pouch is controlling hypoglycemic events showing the islets engraftment was successful and they are surviving. This is likely the " observations" and safety the "early preliminary data".

Either way it appears things are going as planned and has potential to be juicy, hopefully its something Trout bite their teeth into and help spread the word.

I'm curious to see how they are going to go about releasing major news and meeting the disclosure requirements with presenting this at a symposium. Is this symposium going to be live or will a NR come out before he is slated to present at 10:45 on the 3rd?

It will interesting to see if any more patients have been implanted.